Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Winner

Teva Pharmaceutical Industries ( TEVA) pushed the Drugs industry higher today making it today's featured drugs winner. The industry as a whole closed the day up 2.1%. By the end of trading, Teva Pharmaceutical Industries rose 64 cents (1.6%) to $40.07 on average volume. Throughout the day, 3.8 million shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 4.9 million shares. The stock ranged in a price between $39.40-$40.10 after having opened the day at $39.44 as compared to the previous trading day's close of $39.43. Other companies within the Drugs industry that increased today were: AVI BioPharma ( AVII), up 530.5%, Peregrine Pharmaceuticals ( PPHM), up 23%, Catalyst Pharmaceutical Partners ( CPRX), up 21.9%, and Affymax ( AFFY), up 19.2%.

Teva Pharmaceutical Industries Limited develops, manufactures, and sells pharmaceutical products worldwide. Teva Pharmaceutical Industries has a market cap of $34.22 billion and is part of the health care sector. The company has a P/E ratio of 12.7, above the average drugs industry P/E ratio of 12.2 and below the S&P 500 P/E ratio of 17.7. Shares are down 2.7% year to date as of the close of trading on Wednesday. Currently there are 20 analysts that rate Teva Pharmaceutical Industries a buy, no analysts rate it a sell, and nine rate it a hold.

TheStreet Ratings rates Teva Pharmaceutical Industries as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, attractive valuation levels and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and a generally disappointing performance in the stock itself.

On the negative front, Ampio Pharmaceuticals ( AMPE), down 14.5%, Complete Genomics ( GNOM), down 13%, Prima Biomed Ltd. ADR ( PBMD), down 10.3%, and MEI Pharma ( MEIP), down 10%, were all losers within the drugs industry with AstraZeneca ( AZN) being today's drugs industry loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF ( XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech ( BIS).

If you liked this article you might like

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

S&P 500 and Dow Aim for New Records With Broad-Based Gains Ahead of Fed

Dow and S&P 500 Reach New Intraday Highs With Markets in Good Mood Ahead of Fed

Teva's New CEO Brings This Secret Weapon